Lv3
295 积分 2021-09-16 加入
Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia
2个月前
已完结
Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy
2个月前
已完结
Efficacy for LDL-C-lowering and safety of pemafibrate extended-release formulation in patients with statin-intolerant hypercholesterolemia: A phase 3 multicenter, randomized, double-blind, placebo-controlled, parallel-group trial
2个月前
已完结
Pemafibrate for hypertriglyceridemia: a meta-analysis of randomized controlled trials evaluating efficacy and safety outcomes
2个月前
已完结
Factors Affecting Tautomeric Phenomenon of a Novel Potent Immunosuppressant (FK506) on the Design for Injectable Formulation
4个月前
已完结
Solution structure of FK506 from nuclear magnetic resonance and molecular dynamics
4个月前
已完结
Isolation and characterization of the major equilibrium product of FK-520
4个月前
已关闭
Evaluation, synthesis and characterization of tacrolimus impurities
4个月前
已完结
皖公网安备34019202002308
